These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 26648518

  • 1. Tanshinone IIA decreases the migratory ability of AGS cells by decreasing the protein expression of matrix metalloproteinases, nuclear factor κB-p65 and cyclooxygenase-2.
    Su CC.
    Mol Med Rep; 2016 Feb; 13(2):1263-8. PubMed ID: 26648518
    [Abstract] [Full Text] [Related]

  • 2. Tanshinone IIA inhibits gastric carcinoma AGS cells through increasing p-p38, p-JNK and p53 but reducing p-ERK, CDC2 and cyclin B1 expression.
    Su CC.
    Anticancer Res; 2014 Dec; 34(12):7097-110. PubMed ID: 25503137
    [Abstract] [Full Text] [Related]

  • 3. Tanshinone IIA inhibits human gastric carcinoma AGS cell growth by decreasing BiP, TCTP, Mcl‑1 and Bcl‑xL and increasing Bax and CHOP protein expression.
    Su CC.
    Int J Mol Med; 2014 Dec; 34(6):1661-8. PubMed ID: 25270224
    [Abstract] [Full Text] [Related]

  • 4. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitro.
    Zhang Y, Wei RX, Zhu XB, Cai L, Jin W, Hu H.
    Anticancer Drugs; 2012 Feb; 23(2):212-9. PubMed ID: 22126901
    [Abstract] [Full Text] [Related]

  • 5. Tanshinone IIA inhibits gastric carcinoma AGS cells by decreasing the protein expression of VEGFR and blocking Ras/Raf/MEK/ERK pathway.
    Su CC.
    Int J Mol Med; 2018 Apr; 41(4):2389-2396. PubMed ID: 29393362
    [Abstract] [Full Text] [Related]

  • 6. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY, Chang SF, Liao KF, Chiu SC.
    Int J Mol Sci; 2017 Jul 25; 18(8):. PubMed ID: 28757590
    [Abstract] [Full Text] [Related]

  • 7. Tanshinone IIA inhibits BT-20 human breast cancer cell proliferation through increasing caspase 12, GADD153 and phospho-p38 protein expression.
    Yan MY, Chien SY, Kuo SJ, Chen DR, Su CC.
    Int J Mol Med; 2012 May 25; 29(5):855-63. PubMed ID: 22322382
    [Abstract] [Full Text] [Related]

  • 8. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.
    Ho CC, Lai KC, Hsu SC, Kuo CL, Ma CY, Lin ML, Yang JS, Chung JG.
    Hum Exp Toxicol; 2011 Apr 25; 30(4):296-306. PubMed ID: 20498032
    [Abstract] [Full Text] [Related]

  • 9. Integrating transcriptomics and proteomics to show that tanshinone IIA suppresses cell growth by blocking glucose metabolism in gastric cancer cells.
    Lin LL, Hsia CR, Hsu CL, Huang HC, Juan HF.
    BMC Genomics; 2015 Feb 05; 16(1):41. PubMed ID: 25652794
    [Abstract] [Full Text] [Related]

  • 10. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
    Chiu SC, Huang SY, Chen SP, Su CC, Chiu TL, Pang CY.
    Prostate Cancer Prostatic Dis; 2013 Dec 05; 16(4):315-22. PubMed ID: 24042854
    [Abstract] [Full Text] [Related]

  • 11. Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9/nuclear factor kappa B signaling pathway.
    Zhang Y, Li Y, Li Y, Li R, Ma Y, Wang H, Wang Y.
    Mol Med Rep; 2015 Feb 05; 11(2):1366-71. PubMed ID: 25369757
    [Abstract] [Full Text] [Related]

  • 12. Orostachys japonicus inhibits the expression of MMP-2 and MMP-9 mRNA and modulates the expression of iNOS and COX-2 genes in human PMA-differentiated THP-1 cells via inhibition of NF-κB and MAPK activation.
    Kim YI, Park SW, Yoon YK, Lee KW, Lee JH, Woo HJ, Kim Y.
    Mol Med Rep; 2015 Jul 05; 12(1):657-62. PubMed ID: 25760396
    [Abstract] [Full Text] [Related]

  • 13. Tanshinone IIA inhibits Hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression.
    Cheng CY, Su CC.
    Int J Mol Med; 2010 Sep 05; 26(3):379-85. PubMed ID: 20664954
    [Abstract] [Full Text] [Related]

  • 14. Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo.
    Su CC, Chiu TL.
    Oncol Rep; 2016 Aug 05; 36(2):1173-9. PubMed ID: 27277844
    [Abstract] [Full Text] [Related]

  • 15. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
    Zhang J, Kou YB, Zhu JS, Chen WX, Li S.
    Int J Oncol; 2014 Apr 05; 44(4):1268-76. PubMed ID: 24481712
    [Abstract] [Full Text] [Related]

  • 16. Phenethyl isothiocyanate inhibits migration and invasion of human gastric cancer AGS cells through suppressing MAPK and NF-kappaB signal pathways.
    Yang MD, Lai KC, Lai TY, Hsu SC, Kuo CL, Yu CS, Lin ML, Yang JS, Kuo HM, Wu SH, Chung JG.
    Anticancer Res; 2010 Jun 05; 30(6):2135-43. PubMed ID: 20651362
    [Abstract] [Full Text] [Related]

  • 17. Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions.
    Su CC, Chen GW, Lin JG, Wu LT, Chung JG.
    Anticancer Res; 2006 Jun 05; 26(2A):1281-8. PubMed ID: 16619535
    [Abstract] [Full Text] [Related]

  • 18. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
    Tsai MY, Yang RC, Wu HT, Pang JH, Huang ST.
    Cancer Lett; 2011 Nov 28; 310(2):198-206. PubMed ID: 21788102
    [Abstract] [Full Text] [Related]

  • 19. γ-tocotrienol inhibits the invasion and migration of human gastric cancer cells through downregulation of cyclooxygenase-2 expression.
    Zhang YH, Ma K, Liu JR, Wang HX, Tian WX, Tu YH, Sun WG.
    Oncol Rep; 2018 Aug 28; 40(2):999-1007. PubMed ID: 29901169
    [Abstract] [Full Text] [Related]

  • 20. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
    Lai WW, Hsu SC, Chueh FS, Chen YY, Yang JS, Lin JP, Lien JC, Tsai CH, Chung JG.
    Anticancer Res; 2013 May 28; 33(5):1941-50. PubMed ID: 23645742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.